Improving technologies are rapidly cutting the cost of whole genome sequencing, a process that reveals the complete library of a patient’s genetic information. Indeed, the era of the $1,000 genome—a catchphrase for the test’s relative affordability—appears imminent.
But will the wider application of this encyclopedic option in...
Ryan Hernandez, PhD, whose lab studies patterns of genetic variation from populations around the world, using detailed computer modeling to learn more about human evolutionary processes and to discover regions of the genome vital to function and underlying disease, has been named a 2013 Alfred P. Sloan Research Fellow.
...
California tobacco control efforts that cost $2.4 billion over nearly two decades reduced health care costs during that same period by $134 billion, according to a new study co-authored by UCSF School of Pharmacy faculty member James Lightwood, PhD.
“These health care cost savings began to appear almost immediately after the program...
Faculty of the UCSF School of Pharmacy will train Safeway supermarket pharmacists to help their customers quit smoking, using a curriculum originally developed at the School.
The new partnership with Safeway Inc. marks the first time a smoking cessation intervention has been applied systematically across a network of pharmacies.
...
During his illustrious half-century career, UCSF School of Pharmacy faculty member Leslie Benet, PhD, has authored more than 400 peer-reviewed publications, many helping to define the field of pharmacokinetics—how the body absorbs, distributes, metabolizes, and excretes medications—or as he once put it, “what the body does to...
How well do states’ policies address possible conflicts of interest of committee members who decide which drugs get Medicaid reimbursement? The question looms especially large as impending federal health care reform increases the number of patients covered by the state-run drug formularies.
A new study co-authored by Lisa Bero,...
Research at the UCSF School of Pharmacy to develop the first implantable bioartificial kidney recently received exceptional private support: $1 million from the family of the late philanthropists Harry and Diana Hind, and $50,000 from the Patterson Barclay Memorial Foundation.
Both gifts provide major ongoing support...
An updated and expanded review of clinical research papers on drugs and medical devices finds that industry-sponsored studies are more likely to lead to favorable results, including reports of greater benefits and fewer harmful side effects.
The analysis of 48 published studies, covering conditions ranging from heart disease to...